- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Hedge fund's acquisition of impaired notes could allow it to block Warren Buffett's deal to buy Oncor, according to published report.
Warren Buffett's Berkshire Hathaway new $520.7 million position sent shares of Synchrony higher over 4.4% during afternoon trading on Tuesday.
Here are the names we discovered.
DJIA, S&P 500 and Nasdaq all rise slightly on the session.